Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
52.7M
-
Shares change
-
-184K
-
Total reported value, excl. options
-
$190M
-
Value change
-
-$497K
-
Number of buys
-
48
-
Number of sells
-
-36
-
Price
-
$3.60
Significant Holders of Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) as of Q2 2025
118 filings reported holding AVIR - Atea Pharmaceuticals, Inc. - COMMON STOCK as of Q2 2025.
Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.7M shares
of 78.4M outstanding shares and own 67.2% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (8.67M shares), BML Capital Management, LLC (7.61M shares), FMR LLC (5.72M shares), TANG CAPITAL MANAGEMENT LLC (4.89M shares), VANGUARD GROUP INC (4.89M shares), Bain Capital Life Sciences Investors, LLC (2.49M shares), GEODE CAPITAL MANAGEMENT, LLC (1.93M shares), STATE STREET CORP (1.78M shares), DIMENSIONAL FUND ADVISORS LP (1.41M shares), and RENAISSANCE TECHNOLOGIES LLC (1.23M shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.